Written Evidence Apr. 17 2024
Inquiry: NHS leadership, performance and patient safetyFound: critical points has been highlighted by the case of Martha Mills, who died in 2021 after contracting sepsis
Apr. 04 2024
Source Page: Combined antibiotic approved to treat adult patients with severe infections of the urinary tract and hospital-acquired pneumoniaFound: infections and pneumonia can lead to bacteraemia, where bacteria enter the bloodstream, potentially causing sepsis—a
Apr. 04 2024
Source Page: National Patient Safety Alert: Reducing risks for transfusion-associated circulatory overload (NatPSA/2024/004/MHRA)Found: Case 13c.1: An elderly man with renal failure An 82 year old man with type-2 diabetes, sepsis and acute
Mar. 26 2024
Source Page: Research Ventures Catalyst: successful applicationsFound: will focus on respiratory infection, the biggest infectious killer globally and most common cause of sepsis
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the NHS is taking steps with (a) technology developers and (b) academia to help accelerate the introduction of innovative medical solutions.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.
In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help encourage innovation in the development of healthcare technology for at home use.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.
In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.
Mar. 21 2024
Source Page: Access Dstl's published researchFound: Journal Article https://doi.org/10.3390/v14092057 Presymptomatic diagnosis of postoperative infection and sepsis
Written Evidence Mar. 19 2024
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: My child also died of sepsis, not so long ago, just showing that very little has been learnt.
Mar. 15 2024
Source Page: I. Equity in medical devices: Independent Review. Incl. appendices [Chair, Dame Margaret Whitehead]. 130p. II. Government response to the report of the equity in medical devices: independent review. 64p.Found: for a patient with a condition that leads to low blood oxygen levels, such as COVID-19 pneumonia and sepsis
Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what steps they are taking to ensure that their approach to tackling antimicrobial resistance across the world also works to end preventable deaths linked to unclean birth environments.
Answered by Lord Benyon - Minister of State (Foreign, Commonwealth and Development Office)
The UK's Ending Preventable Deaths campaign takes a multisectoral approach which includes tackling antimicrobial resistance, alongside strengthening health systems, sexual and reproductive health and rights, and broader determinants like nutrition, climate and water, sanitation and hygiene. Neonatal sepsis is a particular concern in the context of antimicrobial resistance and as such is where the UK will look to particularly align our work on water sanitation and hygiene, with our work on antimicrobial resistance and the health of mothers and newborns.